Viewing StudyNCT00136487



Ignite Creation Date: 2024-05-05 @ 11:48 AM
Last Modification Date: 2024-10-26 @ 9:13 AM
Study NCT ID: NCT00136487
Status: COMPLETED
Last Update Posted: 2009-12-09
First Post: 2005-08-26

Brief Title: Celecoxib Celebrex Versus Placebo in Men With Recurrent Prostate Cancer
Sponsor: Dana-Farber Cancer Institute
Organization: Dana-Farber Cancer Institute

Conditions & Keywords Data

Conditions:
Name
Prostate Cancer
Keywords:
Name View
Prostate-Specific Antigen View
Prostate Cancer View
Cancer of Prostate View
Cancer of the Prostate View